Redhill Biopharma
RDHL
#10215
Rank
A$6.66 M
Marketcap
$3.77
Share price
3.88%
Change (1 day)
-76.37%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2023 (TTM): A$15.65 Million

According to Redhill Biopharma's latest financial reports the company's current earnings are A$35.74 Million. In 2022 the company made an earning of -A$0.12 Billion, an increase over its 2021 earnings that were of -A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) A$15.65 M-113.97%
2022 -A$0.12 Billion-26.68%
2021 -A$0.16 Billion28.32%
2020 -A$0.12 Billion80.06%
2019 -A$66.13 Million8.97%
2018 -A$60.68 Million-14.76%
2017 -A$71.19 Million55.07%
2016 -A$45.91 Million39.26%
2015 -A$32.97 Million96.9%
2014 -A$16.75 Million0.78%
2013 -A$16.62 Million16.93%
2012 -A$14.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$12.41 B 68,531.52%๐Ÿ‡ซ๐Ÿ‡ท France
A$33.14 B 183,161.32%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.86 B 37,875.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$68.34 M 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-A$0.45 Billion-2,536.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel